142 related articles for article (PubMed ID: 31272759)
1. RETRACTED: Serine/threonine kinase BUB1 promotes proliferation and radio-resistance in glioblastoma.
Yu H; Zhang S; Ibrahim AN; Deng Z; Wang M
Pathol Res Pract; 2019 Aug; 215(8):152508. PubMed ID: 31272759
[TBL] [Abstract][Full Text] [Related]
2. BUB1 and BUBR1 inhibition decreases proliferation and colony formation, and enhances radiation sensitivity in pediatric glioblastoma cells.
Morales AG; Pezuk JA; Brassesco MS; de Oliveira JC; de Paula Queiroz RG; Machado HR; Carlotti CG; Neder L; de Oliveira HF; Scrideli CA; Tone LG
Childs Nerv Syst; 2013 Dec; 29(12):2241-8. PubMed ID: 23728478
[TBL] [Abstract][Full Text] [Related]
3. The FOXM1/BUB1B signaling pathway is essential for the tumorigenicity and radioresistance of glioblastoma.
Ma Q; Liu Y; Shang L; Yu J; Qu Q
Oncol Rep; 2017 Dec; 38(6):3367-3375. PubMed ID: 29039578
[TBL] [Abstract][Full Text] [Related]
4. RETRACTED: Physcion 8-O-β-glucopyranosideregulates cell cycle, apoptosis, and invasion in glioblastoma cells through modulating Skp2.
Li W; Li F; Zhu Y; Song D
Biomed Pharmacother; 2017 Nov; 95():1129-1138. PubMed ID: 28922732
[TBL] [Abstract][Full Text] [Related]
5. FoxM1 Promotes Stemness and Radio-Resistance of Glioblastoma by Regulating the Master Stem Cell Regulator Sox2.
Lee Y; Kim KH; Kim DG; Cho HJ; Kim Y; Rheey J; Shin K; Seo YJ; Choi YS; Lee JI; Lee J; Joo KM; Nam DH
PLoS One; 2015; 10(10):e0137703. PubMed ID: 26444992
[TBL] [Abstract][Full Text] [Related]
6. Dual PLK1 and STAT3 inhibition promotes glioblastoma cells apoptosis through MYC.
Wang H; Tao Z; Feng M; Li X; Deng Z; Zhao G; Yin H; Pan T; Chen G; Feng Z; Li Y; Zhou Y
Biochem Biophys Res Commun; 2020 Dec; 533(3):368-375. PubMed ID: 32962858
[TBL] [Abstract][Full Text] [Related]
7. FOXM1 and STAT3 interaction confers radioresistance in glioblastoma cells.
Maachani UB; Shankavaram U; Kramp T; Tofilon PJ; Camphausen K; Tandle AT
Oncotarget; 2016 Nov; 7(47):77365-77377. PubMed ID: 27764801
[TBL] [Abstract][Full Text] [Related]
8. Polo‑like kinase 4 promotes tumorigenesis and induces resistance to radiotherapy in glioblastoma.
Wang J; Zuo J; Wang M; Ma X; Gao K; Bai X; Wang N; Xie W; Liu H
Oncol Rep; 2019 Apr; 41(4):2159-2167. PubMed ID: 30816483
[TBL] [Abstract][Full Text] [Related]
9. Glioblastoma multiforme formation and EMT: role of FoxM1 transcription factor.
Wang Z; Zhang S; Siu TL; Huang S
Curr Pharm Des; 2015; 21(10):1268-71. PubMed ID: 25506897
[TBL] [Abstract][Full Text] [Related]
10. MELK-dependent FOXM1 phosphorylation is essential for proliferation of glioma stem cells.
Joshi K; Banasavadi-Siddegowda Y; Mo X; Kim SH; Mao P; Kig C; Nardini D; Sobol RW; Chow LM; Kornblum HI; Waclaw R; Beullens M; Nakano I
Stem Cells; 2013 Jun; 31(6):1051-63. PubMed ID: 23404835
[TBL] [Abstract][Full Text] [Related]
11. Modulation of miR-21 signaling by MPS1 in human glioblastoma.
Maachani UB; Tandle A; Shankavaram U; Kramp T; Camphausen K
Oncotarget; 2016 Aug; 7(33):52912-52927. PubMed ID: 25991676
[TBL] [Abstract][Full Text] [Related]
12. KDELR2 Promotes Glioblastoma Tumorigenesis Targeted by HIF1a via mTOR Signaling Pathway.
Liao Z; She C; Ma L; Sun Z; Li P; Zhang X; Wang P; Li W
Cell Mol Neurobiol; 2019 Nov; 39(8):1207-1215. PubMed ID: 31342232
[TBL] [Abstract][Full Text] [Related]
13. RCC2 promotes proliferation and radio-resistance in glioblastoma via activating transcription of DNMT1.
Yu H; Zhang S; Ibrahim AN; Wang J; Deng Z; Wang M
Biochem Biophys Res Commun; 2019 Aug; 516(3):999-1006. PubMed ID: 31277942
[TBL] [Abstract][Full Text] [Related]
14. PLK3 promotes the proneural-mesenchymal transition in glioblastoma via transcriptional regulation of C5AR1.
Yu S; Lv L; Li Y; Ning Q; Liu T; Hu T
Mol Biol Rep; 2023 Oct; 50(10):8249-8258. PubMed ID: 37568042
[TBL] [Abstract][Full Text] [Related]
15. FoxM1 drives ADAM17/EGFR activation loop to promote mesenchymal transition in glioblastoma.
Zhang C; Han X; Xu X; Zhou Z; Chen X; Tang Y; Cheng J; Moazzam NF; Liu F; Xu J; Peng W; Du F; Zhang B; Song Z; Zeng J; Gong A
Cell Death Dis; 2018 May; 9(5):469. PubMed ID: 29700308
[TBL] [Abstract][Full Text] [Related]
16. PLK4 is a determinant of temozolomide sensitivity through phosphorylation of IKBKE in glioblastoma.
Zhang Z; Wang Z; Huang K; Liu Y; Wei C; Zhou J; Zhang W; Wang Q; Liang H; Zhang A; Wang G; Zhen Y; Han L
Cancer Lett; 2019 Feb; 443():91-107. PubMed ID: 30529153
[TBL] [Abstract][Full Text] [Related]
17. MiR-338-3p inhibits growth of glioblastoma through targeting MAP4K3.
Song Y; Zhang F; Li L; Song B; Xu J; Wang G; Zheng Z
Minerva Med; 2021 Aug; 112(4):531-533. PubMed ID: 31578840
[No Abstract] [Full Text] [Related]
18. ILK silencing inhibits migration and invasion of more invasive glioblastoma cells by downregulating ROCK1 and Fascin-1.
Louca M; Zaravinos A; Stylianopoulos T; Gkretsi V
Mol Cell Biochem; 2020 Aug; 471(1-2):143-153. PubMed ID: 32506247
[TBL] [Abstract][Full Text] [Related]
19. Sprouty2 enhances the tumorigenic potential of glioblastoma cells.
Park JW; Wollmann G; Urbiola C; Fogli B; Florio T; Geley S; Klimaschewski L
Neuro Oncol; 2018 Jul; 20(8):1044-1054. PubMed ID: 29635363
[TBL] [Abstract][Full Text] [Related]
20. Amlexanox, a selective inhibitor of IKBKE, generates anti-tumoral effects by disrupting the Hippo pathway in human glioblastoma cell lines.
Liu Y; Lu J; Zhang Z; Zhu L; Dong S; Guo G; Li R; Nan Y; Yu K; Zhong Y; Huang Q
Cell Death Dis; 2017 Aug; 8(8):e3022. PubMed ID: 29048430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
